These findings confirmed that Non-Luminal BC, including HER2 and basal-like, was a “protective” factor for bone metastases with a high significance, lowering the risk by 80% (OR: 0.2), and highlighting that the Luminal subtype (especially Luminal A) is responsible for almost all bone distant recurrences. The gene discussed is ERBB2; the disease is breast cancer.